300642 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Tellgen Corp. engages in the developing, manufacturing and marketing of molecular diagnostic products. It distributes automated workflow solutions for research and clinical diagnostics laboratories in the life sciences sector. Tellgen produces the products for tumor, infectious and reproductive disease diagnostics. The company was founded on November 6, 2003 and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
300642 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company